PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Join your clinician colleagues and expert faculty for PrimaryCareNOW: A Pri-Med Virtual Conference, on Thursday–Friday, February 18–19.

Moderated by Charles Vega, MD, FAAFP, and Ty J. Gluckman, MD, FACC, FAHA, this two-day learning experience will provide you with evidence-based sessions that span the diverse therapeutic areas that touch primary care, allow opportunities for interactive Q&A, and offer timely medical updates to keep you informed on the most current clinical strategies relevant to your daily practice.

Earn up to 12.50
AMA PRA Category 1 Credits™ and 12.50 ABIM Medical Knowledge MOC Points, or 12.50 AANP contact hours of continuing education, including 6.94 hours of pharmacology, by attending the full conference. 

Your free registration includes the full conference, but feel free to join the sessions that work with your schedule. 
Agenda and details are subject to change.

To register for this virtual conference, you will be asked to sign in to your Pri-Med account. If you do not have an account, you can create your free account now, which takes less than two minutes.

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8-9AM ET    CME/CE Accredited Session

Psychiatry

 


What happens when your patient does not respond to a SSRI?  What happens when your patient does not respond to treatment? This session will review how to manage these more challenging cases of depression that are all too common in primary care settings.

Jeffrey Rado, MD, MPH, FAPA

Associate Professor, Northwestern University Feinberg School of Medicine, Chicago, IL

9:10-10:10AM ET    CME/CE Accredited Session

Infectious Disease

Managing Influenza: Practical Strategies For Primary Care 

Daniel A. Solomon, MD | Charles Vega, MD, FAAFP

 


This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.

Daniel A. Solomon, MD

Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine, Harvard Medical School, Boston, MA

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by an educational grant from Genentech, a member of the Roche Group

10:20-11:10AM ET    Non-CME Industry Theater

Gastroenterology

 


*This is a hypothetical case and not an actual patient    

Uncover the cause of the patient's symptoms in this virtual case study and consider if this could apply to any patients you manage.

 

Sponsored by Takeda Pharmaceuticals U.S.A., Inc.

10:20-11:10AM ET    Non-CME Industry Theater

Pulmonology

Robert Keith

 


Early and accurate diagnosis of chronic obstructive pulmonary disease (COPD) followed by optimal management are very important. This educational activity will discuss the diagnosis of COPD, goals for treatment, pharmacological management, and the role of inhaled therapy and inhaler choice in the management of patients with COPD.

Robert Keith

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

11:15AM-12:15PM ET    CME/CE Accredited Session

Hematology

 


This session reviews the latest evidence-based data regarding iron deficiency anemia (IDA) and offers practical clinical insight into the diagnosis and management of this common condition. Through a series of case presentations, the presenting gastroenterologist discusses the common but subtle manifestations of IDA, proactive strategies for recognizing patients at risk of IDA, and the current evidence base for using oral and intravenous iron therapies effectively in practice. These practical pearls and pitfalls are intended to help optimize the care of IDA in various patient populations seen in the primary care setting. 

Neilanjan Nandi, MD, FACP

Associate Professor of Clinical Medicine, Inflammatory Bowel Diseases Center, University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia, PA

Supported by American Regent, Inc.

12:25-1:25PM ET    CME/CE Accredited Session

Cardiology

Advancing Patient Care by Reducing Cardiovascular Risk Beyond Statin Therapy 

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC | Gregory S. Pokrywka, MD, FACP, FNLA, FASCP, NCMP

 


Session Overview to Come

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center, Professor of Medicine, Harvard Medical School, Boston, MA

Gregory S. Pokrywka, MD, FACP, FNLA, FASCP, NCMP

Assistant Professor Medicine, John Hopkins University School of Medicine, Director, Baltimore Lipid Center, Baltimore, MD

Supported by Amarin Pharma Inc.

1:35-2:20PM ET    Non-CME Industry Theater

Cardiology

Rosemarie Lajara, MD

 


This program will review multiple clinical trials and approved indications for JARDIANCE. The presentation will cover efficacy and safety data, as well as the dosing information for JARDIANCE. Attendees will also have the opportunity to ask the faculty questions about the data presented.

Rosemarie Lajara, MD

Southern Endocrinology, PA, Clinical Associate Professor of Medicine, UT Southwestern Medical Center, Dallas, Texas

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

1:35-2:20PM ET    Non-CME Industry Theater

Dermatology

Elizabeth (Lisa) Swanson, MD

 


Come learn about the burden and management of uncontrolled, moderate-to-severe atopic dermatitis in your appropriate  patients and a treatment option that  may help them.

@2021 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved 01/2021 DER.20.12.0002

jpg

Elizabeth (Lisa) Swanson, MD

Board Certified Dermatologist and Pediatric Dermatologist, Ada West Dermatology, St Luke's Children's Hospital, Boise, Idaho

Sponsored by Regeneron Pharmaceuticals

2:30-3:30PM ET    CME/CE Accredited Session

Cardiology

The Top Questions I Most Often Get Asked About: Diabetes, Atrial Fibrillation, and Mild Cognitive Impairment 

Martin J. Abrahamson, MD, FACP | Ty J. Gluckman, MD, FACC, FAHA | Lee A. Lindquist, MD, MPH, MBA

 


What do primary care providers need to know to know about diabetes, atrial fibrillation, and mild cognitive impairment? Join endocrinologist Martin Abrahamson, cardiologist Ty Gluckman, and geriatrician Lee Lindquist as they review important questions, they get asked about these three topics!

Martin J. Abrahamson, MD, FACP

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR,

Lee A. Lindquist, MD, MPH, MBA

Chief of Geratrics, Northwestern University Feinberg School of Medicine, Chicago, IL

Supported by Commercial Supporter here

3:40-4:40PM ET    CME/CE Accredited Session

 


One in fifty people in the U.S. has an unruptured brain aneurysm, and one ruptures every 18 minutes. Despite low frequency, brain aneurysms are high in mortality, because the lack of a timely diagnosis often leads to death. Complicating matters more, many of the symptoms are associated with other less dangerous conditions, such as influenza or stress. This session will describe the importance of early detection, since brain aneurysms are treatable via proper identification, and will highlight risk factors and populations who are most vulnerable. Faculty will also review treatment options for clinicians to recognize or use in practice. 

Christopher S. Ogilvy, MD

Director, Endovascular and Operative Neurovascular Surgery, BIDMC Brain Aneurysm Institute, Professor of Neurosurgery, Harvard Medical School, Boston, MA

4:50-5:35PM ET    Non-CME Industry Theater

Endocrinology

 


Evaluate when the guidelines recommend GLP-1 RA use for T2D treatment. Review the glucose-dependent mechanism of action, safety, and dosing of a once-weekly GLP-1 RA.  Discuss the efficacy and safety data from pivotal T2D glycemic control trials and from the cardiovascular outcomes trial.
 

 

Sponsored by Novo Nordisk Inc.

8-9AM ET    CME/CE Accredited Session

9:10-10:10AM ET    CME/CE Accredited Session

Infectious Disease

COVID-19 Panel Discussion 

Paul E. Sax, MD | Mary W. Montgomery MD

 


These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care, and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA

Default Biography Avatar

Mary W. Montgomery MD

Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine, Harvard Medical School, Boston, MA

10:20-11:05AM ET    Non-CME Industry Theater

Pulmonology

Pamela Kushner, MD, FAAFP

 


This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center, Director, Kushner Wellness Center, Los Alamitos, CA

Sponsored by GlaxoSmithKline

10:20-11:05AM ET    Non-CME Industry Theater

Endocrinology

Eden Miller, DO

 


The objective of this program is to communicate the importance of addressing cardiovascular risk in patients with type 2 diabetes. The program will cover data on prevalence, morbidity, mortality, and intensive versus conventional glucose lowering on macrovascular complications. In addition, the program will review guidance from leading medical associations that is based upon completed cardiovascular outcome trials of antihyperglycemic medications in patients with type 2 diabetes.

Eden Miller, DO

Family Practice Physician , Diabetes and Obesity Care, Bend Oregon

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

11:15AM-12:15PM ET    CME/CE Accredited Session

Dermatology

 


In recent years, many advances have occurred in the medical management of dermatologic disease. What's Poppin? will delve into the diagnosis and management of skin disorders seen commonly in primary care and will discuss updated therapeutic options.  

Jennifer Haley, MD

Associate Clinical Professor of Medicine/Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA

12:25-1:10PM ET    Non-CME Industry Theater

Cardiology

Matthew J. Budoff, MD, FACC, FAHA

 


The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF, as well as treatments currently under.

Matthew J. Budoff, MD, FACC, FAHA

Professor of Medicine, UCLA, Endowed Chair of Preventive Cardiology, Lundquist Institute, Torrance, California

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

12:25-1:10PM ET    Non-CME Industry Theater

Neurology

 


Session overview to come.

Sponsored by ACADIA Pharmaceuticals Inc.

1:20-4:50PM ET    CME/CE Accredited Session

Pain

Strategies for Effective Pain Management 

Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP

 


The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain versus the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse to manage patients’ pain and medication use optimally.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). 

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Opioid Analgesic REMS Program Companies

5-5:45PM ET    Non-CME Industry Theater

Cardiology

 


  • Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
  • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population
  • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial
 

Victor Howard, MD, FACC

Senior Medical Director, Cardiovascular US Medical Affairs, AstraZeneca

Dr. Howard was born in Charleston, West Virginia and is the second eldest of five siblings. His family moved to Texas at an early age, but ultimately all transitioned to Florida. He received his Bachelor of Science undergraduate degree and medical degree from the University of Miami with AΩA honors. He completed his residency in Internal Medicine at Parkland Hospital/University of Texas Southwestern Medical School in Dallas, Texas. He completed his fellowship in cardiology at the Methodist Hospital/Texas Medical Ctr., Baylor College of Medicine in Houston, Texas.

He returned to Florida to practice general and interventional cardiology on the southwest coast of Florida for over 28 years. After a few years in a multispecialty practice he transitioned to building the largest single specialty practice in the state of Florida based in Sarasota. During that time he developed a highly regarded cardiology practice, but also was extensively involved in education, external consultation, and participation in over 60 clinical research trials. In March, 2014 he transitioned to a field medical directorship in the cardiovascular division of medical affairs at Astra Zeneca. His primary responsibility is to provide scientific and clinical expertise with respect to brand medical strategy as well as to develop enhanced peer relationships with physicians and institutions in the cardiovascular arena. His involvement extends to areas such as investigator sponsored research, support of clinical trials and major conferences/advisory boards and education.

He resides in Sarasota, Florida with his wife Tiffany and three children Nathan, Nick, and Sophia. He enjoys the symphony, opera, and theater as well as spending time with his family whether it be relaxing on the beach or hiking and skiing in the mountains.

Sponsored by AstraZeneca